Your browser doesn't support javascript.
loading
Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes.
Kanagal-Shamanna, Rashmi; Montalban-Bravo, Guillermo; Sasaki, Koji; Darbaniyan, Faezeh; Jabbour, Elias; Bueso-Ramos, Carlos; Wei, Yue; Chien, Kelly; Kadia, Tapan; Ravandi, Farhad; Borthakur, Gautam; Soltysiak, Kelly A; Routbort, Mark; Patel, Keyur; Pierce, Sherry; Medeiros, L Jeffrey; Kantarjian, Hagop M; Garcia-Manero, Guillermo.
Afiliação
  • Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Darbaniyan F; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bueso-Ramos C; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wei Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chien K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Soltysiak KA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Routbort M; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Patel K; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Medeiros LJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer ; 127(19): 3552-3565, 2021 10 01.
Article em En | MEDLINE | ID: mdl-34161603
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Síndromes Mielodisplásicas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Síndromes Mielodisplásicas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Ano de publicação: 2021 Tipo de documento: Article